Orally administration of cerium oxide nanozyme for computed tomography imaging and anti-inflammatory/anti-fibrotic therapy of inflammatory bowel disease

BACKGROUND: Inflammatory bowel disease (IBD) is a chronic nonspecific disease with unknown etiology. Currently, the anti-inflammatory therapeutic approaches have achieved a certain extent of effects in terms of inflammation alleviation. Still, the final pathological outcome of intestinal fibrosis ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yameng, Cheng, Kai, Yang, Mei, Deng, Zhichao, Ma, Yana, Yan, Xiangji, Zhang, Yuanyuan, Jia, Zhenzhen, Wang, Jun, Tu, Kangsheng, Liang, Jie, Zhang, Mingzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854161/
https://www.ncbi.nlm.nih.gov/pubmed/36658555
http://dx.doi.org/10.1186/s12951-023-01770-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9854161/
https://www.ncbi.nlm.nih.gov/pubmed/36658555
http://dx.doi.org/10.1186/s12951-023-01770-0

Ejemplares similares